Company news

Lobe Sciences Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Lobe Sciences, Ltd. Announces the Acquisition of Altemia(TM) & Company

April 18, 2023

Lobe Sciences to Present at Sequire Cannabis & Psychedelics Conference April 5, 2023

April 4, 2023

Lobe Sciences Ltd. Announces That The Drug Enforcement Administration Has Issued The Initial 2023 Quota Allowing Export Of L-130

March 22, 2023

Chronic Cluster Headaches No More: The Promise Of Lobe Sciences' At-Home Psychedelic Treatments Without The Trip!

March 1, 2023

Lobe Sciences Ltd. Announces Exclusive Collaboration with Quality Chemical Laboratories LLC

February 21, 2023

Lobe Sciences, Ltd. Announces USD$250,000 Convertible Note Financing and Warrant Issuance

February 10, 2023

Lobe Sciences Congratulates Australia for Becoming the First Nation to Approve the Medicinal Use of Psilocybin and MDMA

February 6, 2023

Lobe Sciences, Ltd. Enters Collaborative Clinical Research Agreement with Integrative Headache Medicine of New York to Study the Effects of L-130 in the Treatment of Chronic Cluster Headache

January 26, 2023

Lobe Sciences Board of Directors Elects to Receive Shares in Lieu of Cash for All Board Fees

January 23, 2023

Lobe Sciences Provides Update For 2023 Milestones

January 18, 2023

Trippy Trading: Top Psychedelic Stocks For 2023

January 17, 2023

← Newer news releases

Decks

The 5 newest of 6 decks. Every deck is listed under its year.